# Effects of Telmisartan/Hydrochlorothiazide Treatment in Hypertensive Patients Under Real-life Setting

> **NCT01392534** · — · COMPLETED · sponsor: **Bayer** · enrollment: 1586 (actual)

## Conditions studied

- Primary Hypertension

## Interventions

- **DRUG:** Telmisartan/hydrochlorothiazide (Pritor Plus, BAY98-7103)

## Key facts

- **NCT ID:** NCT01392534
- **Lead sponsor:** Bayer
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2010-07
- **Primary completion:** 2010-12
- **Final completion:** 2010-12
- **Target enrollment:** 1586 (ACTUAL)
- **Last updated:** 2012-07-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01392534

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01392534, "Effects of Telmisartan/Hydrochlorothiazide Treatment in Hypertensive Patients Under Real-life Setting". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT01392534. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*